esle { }

Authoring of TR 56-3 Phase Appropriate Application of GMPs for Vaccines

Application Deadline
24 May, 2024
Openings
15
Type
Virtual Writing
Location
Virtual, in-person

This annex to TR 56 will address specific aspects of vaccine manufacturing and help provide insight as to how to apply GMPs to the accelerated development process involved with vaccines, including application of prior knowledge and platform technologies.

This is a virtual and in-person opportunity.

Available to Members only.

Skills

  • Biotech
  • Quality and Compliance